I agree that this site is using cookies. You can find further informations here.
X
Mocci, Giammarco
69  results:
Search for persons X
?
1

Tu1819 REAL-LIFE EFFECTIVENESS AND SAFETY OF TOFACITINIB AN..:

Noviello, Daniele ; Savarino, Edoardo V. ; Fries, Walter...
Gastroenterology.  166 (2024)  5 - p. S-1421 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Ustekinumab in the Treatment of Inflammatory Bowel Diseases..:

Mocci, Giammarco ; Tursi, Antonio ; Onidi, Francesca Maria...
Journal of Clinical Medicine.  13 (2024)  5 - p. 1519 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Adalimumab biosimilar ABP 501 is equally effective and safe..:

Mocci, Giammarco ; Cingolani, Arianna ; Orrù, Giorgia...
Frontiers in Gastroenterology.  2 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Insights into Mesalazine Use in Clinical Practice of Young ..:

Nardone, Olga Maria ; Marasco, Giovanni ; Lopetuso, Loris Riccardo...
Journal of Clinical Medicine.  12 (2023)  5 - p. 2005 , 2023
Link: https://doi.org/10.3390/..
 
?
5

An Objective Comparison of Vedolizumab and Ustekinumab Effe..:

Onali, Sara ; Pugliese, Daniela ; Caprioli, Flavio Andrea...
American Journal of Gastroenterology.  117 (2022)  8 - p. 1279-1287 , 2022
Link: https://doi.org/10.14309..
 
?
6

Comparison of Performances of Adalimumab Biosimilars SB5, A..:

Tursi, Antonio ; Mocci, Giammarco ; Allegretta, Leonardo...
Inflammatory Bowel Diseases.  29 (2022)  3 - p. 376-383 , 2022
Link: https://doi.org/10.1093/..
 
?
7

Impact of SARS-CoV-2 Infection on the Course of Inflammator..:

Papa, Alfredo ; Scaldaferri, Franco ; Covino, Marcello...
Biomedicines.  10 (2022)  4 - p. 843 , 2022
Link: https://doi.org/10.3390/..
 
?
8

Adalimumab Biosimilar GP2017 versus Adalimumab Originator i..:

Mocci, Giammarco ; Bodini, Giorgia ; Allegretta, Leonardo...
Biomedicines.  10 (2022)  8 - p. 1799 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Letter: ustekinumab for the treatment of post‐surgical and ..:

Tursi, Antonio ; Mocci, Giammarco ; Picchio, Marcello..
Alimentary Pharmacology & Therapeutics.  53 (2021)  7 - p. 859-860 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Collagenous Sprue and Olmesartan: another pathological cond..:

Del Sordo, Rachele ; Villanacci, Vincenzo ; Oberti, Arianna..
Digestive and Liver Disease.  53 (2021)  11 - p. 1524-1526 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Two‐year effectiveness and safety of golimumab in ulcerativ..:

Pugliese, Daniela ; Privitera, Giuseppe ; Rogai, Francesca...
United European Gastroenterology Journal.  9 (2021)  1 - p. 102-109 , 2021
Link: https://doi.org/10.1177/..
 
?
12

Long‐term outcomes of acute severe ulcerative colitis in th..:

Festa, Stefano ; Scribano, Maria L. ; Pugliese, Daniela...
United European Gastroenterology Journal.  9 (2021)  4 - p. 507-516 , 2021
Link: https://doi.org/10.1177/..
 
?
13

Long-term, Real-life, Observational Study in Treating Outpa..:

Maconi, Giovanni ; Bergna, Irene Maria Bambina ; Picchio, Marcello...
Journal of Gastrointestinal and Liver Diseases.  30 (2021)  4 - p. 456-461 , 2021
Link: https://doi.org/10.15403..
 
?
14

COVID-19 Vaccination Willingness and Hesitancy in Patients ..:

Costantino, Andrea ; Noviello, Daniele ; Conforti, Francesco Simone...
Inflammatory Bowel Diseases.  28 (2021)  3 - p. 474-478 , 2021
Link: https://doi.org/10.1093/..
 
?
15

Effect of Ustekinumab on Extraintestinal Diseases in Refrac..:

Tursi, Antonio ; Mocci, Giammarco ; Maconi, Giovanni
Journal of Crohn's and Colitis.  15 (2021)  8 - p. 1399-1400 , 2021
Link: https://doi.org/10.1093/..
 
1-15